Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA for Fatigue in SLE and pSS
NCT00391924Phase 2Completed
- Start
- May 2000
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in systemic lupus erythematosus (SLE) and Sjögren's syndrome comparing Dehydroepiandrosterone with Placebo (2 arms). Primary endpoints: General fatigue at 18 months, Depressive mood at 18 months and 2 more. Started May 2000; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
systemic lupus erythematosus (SLE)Sjögren's syndrome
Beyond the preview
Go deeper on NCT00391924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391924.